Expand BCTX Menu
BCTX MENU

BCTX Stock Posts


BCTX stock declines -20.8% in premarket,

Premarket Decliner

BCTX Briacell Therapeutics Corp. - Common Shares6.98+0.43+6.6%

Premarket:5.53-1.45 (-20.8%)

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+ in Prostate Cancer

Globe NewswireMon, 25-Aug 7:30 AM
BCTX stock declines -19.2% in premarket,

Premarket Decliner

BCTX Briacell Therapeutics Corp. - Common Shares2.91+0.02+0.7%

Premarket:2.35-0.56 (-19.2%)

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS Metastatic Breast Cancer Study

Globe NewswireWed, 9-Jul 7:30 AM
BCTX stock declines -8.8% in after hours trading. See the latest news.

After Hours Decliner

BCTX Briacell Therapeutics Corp. - Common Shares6.03+0.60+11.1%

After Hours:5.50-0.53 (-8.8%)

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

Globe NewswireThu, 24-Apr 8:00 PM
Unusual Option Volume

BCTX Briacell Therapeutics Corp. - Common Shares0.78-0.46 (-37.1%)

Briacell Therapeutics Corp. - Common Shares trades 2,906 contracts. The company has the following event: Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting on Nov 8, 2024. News: BriaCell Therapeutics Announces $5 Million Offering
View Details...
Unusual Option Volume

BCTX Briacell Therapeutics Corp. - Common Shares1.28+0.66 (+106.8%)

Briacell Therapeutics Corp. - Common Shares trades 2,809 contracts. The company has the following event: Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting on Nov 8, 2024. News: BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer
View Details...
Unusual Option Volume

BCTX Briacell Therapeutics Corp. - Common Shares3.30+0.07 (+2.2%)

Briacell Therapeutics Corp. - Common Shares trades 2,120 contracts. The highest volume is in the 19-Jul-24 7.5 calls, which is 127.3% above the current price.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes